Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host? DOI Creative Commons
Jun Zou, Baisheng Xu,

Peiyue Luo

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 19, 2024

In recent years, the role of gut microbiota (GM) in bladder cancer has attracted significant attention. Research indicates that GM not only contributes to carcinogenesis but also influences efficacy adjuvant therapies for cancer. Despite this, interventions targeting have been widely employed prevention and treatment cancer, mainly due incomplete understanding complex interactions between host flora. Simultaneously, aberrantly expressed non-coding RNAs (ncRNAs) frequently associated with playing crucial roles processes such as cell proliferation, invasion, drug resistance. It is known regulation GM-mediated pathophysiological partly regulated through epigenetic pathways. At same time, ncRNAs are increasingly regarded signaling molecules involved regulation. Accordingly, this review analyzes closely related context occurrence treatment, summarizes their interaction cancer-related phenotypes. The aim delineate a regulatory network provide new perspective study

Язык: Английский

Exploring cell death pathways in oral cancer: mechanisms, therapeutic strategies, and future perspectives DOI Creative Commons

Chenyi Zhao

Discover Oncology, Год журнала: 2025, Номер 16(1)

Опубликована: Март 26, 2025

Oral squamous cell carcinoma (OSCC) represents a significant global health challenge, characterized by aggressive progression and poor therapeutic response despite advances in treatment modalities. This review provides comprehensive analysis of diverse death mechanisms OSCC, encompassing traditional pathways (apoptosis, autophagy, necrosis), newly (ferroptosis, pyroptosis, necroptosis), emerging (cuproptosis, anoikis, parthanatos, entosis). By examining the molecular basis these pathways, particularly crucial roles p53 signaling miRNA regulation, we highlight how their dysregulation contributes to resistance tumor progression. The synthesizes recent evidence demonstrating complex interplay between ten distinct impact on microenvironment immune response. We evaluate innovative approaches that target including novel small molecules, combination strategies, immunomodulatory treatments exploit specific enhance efficacy. Special attention is given personalized medicine strategies consider individual characteristics pathway profiles. integrating current challenges with future research directions, this framework for developing more effective can leverage multiple overcome therapy improve outcomes oral cancer patients.

Язык: Английский

Процитировано

0

Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer DOI Creative Commons
Yiwei Wang, Ting Xu, Hongcheng Wang

и другие.

Cancer Cell International, Год журнала: 2024, Номер 24(1)

Опубликована: Июль 10, 2024

Pancreatic cancer, characterized by its poor prognosis, exhibits a marked resistance to conventional chemotherapy and immunotherapy, underscoring the urgent need for more effective treatment modalities. In light of this, present study is designed assess potential antineoplastic efficacy combined regimen involving tetrandrine, plant-derived alkaloid, autophagy inhibitors in context pancreatic cancer. Electron microscopy immunoblots showed that tetrandrine promoted formation autophagosomes upregulation LC3II downregulation p62 expression, indicating induced cancer cells. Western blot revealed inhibited phosphorylation AKT mTOR, as well expression Bcl-2, while upregulating Beclin-1 expression. Moreover, transcription protein ATG7. Following combination apoptotic rate cell death significantly increased Consistent results were obtained when ATG7 was silenced. Additionally, generation ROS, which involved activation apoptosis. Further investigation upon inhibition, ROS accumulated cells, resulting decreased mitochondrial membrane further induction The treating subcutaneous xenograft tumors with chloroquine validated inhibition enhances toxicity against vivo. Altogether, our demonstrates induces cytoprotective Inhibiting tetrandrine-induced promotes accumulation

Язык: Английский

Процитировано

1

Exploring the oncogenic role of RGS19 in bladder cancer progression and prognosis DOI
Lei Yan,

Guangyue Luo,

Chengxiang Han

и другие.

Acta Histochemica, Год журнала: 2024, Номер 126(8), С. 152212 - 152212

Опубликована: Ноя. 1, 2024

Язык: Английский

Процитировано

0

Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells DOI Creative Commons
Carmela Spagnuolo,

Francesco Mautone,

Anna Maria Iole Meola

и другие.

Molecules, Год журнала: 2024, Номер 29(21), С. 5176 - 5176

Опубликована: Окт. 31, 2024

Bladder cancer, which has a rising incidence, is the 10th most common cancer. The transitional cell carcinoma histotype aggressive and often current therapies are ineffective. We investigated anti-proliferative effect of quercetin, natural flavonoid, in combination with alkylating agent mafosfamide (MFA) on two human bladder cancer lines, namely RT112 J82, representing progression from low-grade to high-grade tumors, respectively. In both types, combined treatment led synergic reduction viability confirmed by index less than one, though different biological responses were noted. J82 cells, MFA alone and, lesser extent, quercetin caused cycle arrest G2/M phase, but only triggered apoptotic death. contrast, induced autophagy, evidenced autophagosome formation increase LC-3 lipidation. Interestingly, synergistic was observed when cells pre-treated for 24 h before adding not reverse order. This suggests that may help overcome resistance apoptosis. Although further studies needed, investigating effects could elucidate mechanisms drug treatment.

Язык: Английский

Процитировано

0

Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host? DOI Creative Commons
Jun Zou, Baisheng Xu,

Peiyue Luo

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 19, 2024

In recent years, the role of gut microbiota (GM) in bladder cancer has attracted significant attention. Research indicates that GM not only contributes to carcinogenesis but also influences efficacy adjuvant therapies for cancer. Despite this, interventions targeting have been widely employed prevention and treatment cancer, mainly due incomplete understanding complex interactions between host flora. Simultaneously, aberrantly expressed non-coding RNAs (ncRNAs) frequently associated with playing crucial roles processes such as cell proliferation, invasion, drug resistance. It is known regulation GM-mediated pathophysiological partly regulated through epigenetic pathways. At same time, ncRNAs are increasingly regarded signaling molecules involved regulation. Accordingly, this review analyzes closely related context occurrence treatment, summarizes their interaction cancer-related phenotypes. The aim delineate a regulatory network provide new perspective study

Язык: Английский

Процитировано

0